8-K
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0001558370-21-016327
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading plx-20211124x8k.htm…